Item Type | Name |
Concept
|
Chromosomes, Human, Pair 11
|
Concept
|
Chromosomes, Human, Pair 2
|
Concept
|
Chromosomes, Human, Pair 6
|
Concept
|
Chromosomes, Human, Pair 8
|
Concept
|
Chromosomes, Human, Pair 1
|
Concept
|
Chromosomes, Human, Pair 15
|
Concept
|
Chromosomes, Human, Pair 21
|
Concept
|
Chromosomes, Human, Pair 3
|
Concept
|
Chromosomes, Human, 4-5
|
Concept
|
Chromosomes, Human, Pair 12
|
Concept
|
Chromosomes, Human, Pair 14
|
Concept
|
Chromosomes, Human, 6-12 and X
|
Concept
|
Chromosomes, Human, Pair 13
|
Concept
|
Chromosomes, Human, Pair 22
|
Concept
|
Chromosomes, Human, Pair 4
|
Concept
|
Chromosomes, Human, Pair 5
|
Concept
|
Chromosomes, Human, Pair 7
|
Concept
|
Chromosomes, Human, 13-15
|
Concept
|
Chromosomes, Human, Pair 20
|
Concept
|
Chromosomes, Human, 16-18
|
Concept
|
Chromosomes, Human, 21-22 and Y
|
Concept
|
Chromosomes, Human, Pair 17
|
Concept
|
Chromosomes, Human, Pair 9
|
Concept
|
Chromosomes, Human, 19-20
|
Concept
|
Chromosomes, Human
|
Concept
|
Chromosomes, Human, Pair 16
|
Academic Article
|
Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases.
|
Academic Article
|
Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia.
|
Academic Article
|
Polymerase chain reaction-based diagnosis of del (5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval.
|
Academic Article
|
Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases.
|
Academic Article
|
Familial myeloid leukemia associated with loss of the long arm of chromosome 5.
|
Academic Article
|
Myeloid leukemia after hematotoxins.
|
Academic Article
|
Balanced translocations involving chromosome bands 11q23 and 21q22 in therapy-related leukemia.
|
Academic Article
|
Refinement of the smallest commonly deleted segment of chromosome 20 in malignant myeloid diseases and development of a PAC-based physical and transcription map.
|
Academic Article
|
Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map.
|
Academic Article
|
Prevalence of the inactivating 609C-->T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia.
|
Academic Article
|
dic(5;17): a recurring abnormality in malignant myeloid disorders associated with mutations of TP53.
|
Academic Article
|
CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapy.
|
Academic Article
|
Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method.
|
Academic Article
|
Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q).
|
Academic Article
|
t(1;3)(p36;p21) is a recurring therapy-related translocation.
|
Academic Article
|
Polymorphisms in the MLL breakpoint cluster region (BCR).
|
Academic Article
|
Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a study of the Cancer and Leukaemia Group B.
|
Academic Article
|
Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature.
|
Academic Article
|
Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461.
|
Academic Article
|
A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies.
|
Academic Article
|
Trisomy 6: a recurring cytogenetic abnormality associated with marrow hypoplasia.
|
Academic Article
|
Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
|
Academic Article
|
Myelodysplasia: when to treat and how.
|
Academic Article
|
Gene expression profiles in acute myeloid leukemia with common translocations using SAGE.
|
Academic Article
|
Deletions of interferon genes in acute lymphoblastic leukemia.
|
Academic Article
|
Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11).
|
Academic Article
|
The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma.
|
Academic Article
|
Acute lymphoblastic leukemia: older patients and newer drugs.
|
Academic Article
|
Clinicopathologic manifestations and breakpoints of the t(3;5) in patients with acute nonlymphocytic leukemia.
|
Academic Article
|
Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes.
|
Academic Article
|
Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis.
|
Academic Article
|
Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II.
|
Academic Article
|
A morphologic and cytochemical study of acute myelomonocytic leukemia with abnormal marrow eosinophils associated with inv(16)(p13q22).
|
Academic Article
|
Association of a chromosomal 3;21 translocation with the blast phase of chronic myelogenous leukemia.
|
Academic Article
|
Assignment of the GM-CSF, CSF-1, and FMS genes to human chromosome 5 provides evidence for linkage of a family of genes regulating hematopoiesis and for their involvement in the deletion (5q) in myeloid disorders.
|
Academic Article
|
Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia.
|
Academic Article
|
Der(5)t(5;7)(q11.2;p11.2): a new recurring abnormality in malignant myeloid disorders.
|
Academic Article
|
Acute myelomonocytic leukemia with abnormal eosinophils presenting as an ovarian mass: a report of two cases and a review of the literature.
|
Academic Article
|
Assignment of CSF-1 to 5q33.1: evidence for clustering of genes regulating hematopoiesis and for their involvement in the deletion of the long arm of chromosome 5 in myeloid disorders.
|
Academic Article
|
Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders.
|
Academic Article
|
Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission.
|
Academic Article
|
Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del(5q).
|
Academic Article
|
Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association.
|
Academic Article
|
Detection of MLL gene rearrangements in adult acute lymphoblastic leukemia. A Cancer and Leukemia Group B study.
|
Academic Article
|
Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders.
|
Academic Article
|
Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.
|
Academic Article
|
Response to 5-azacytidine in patients with refractory acute nonlymphocytic leukemia and association with chromosome findings.
|
Academic Article
|
Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion.
|
Academic Article
|
A recurring chromosome rearrangement, dic(16;22), in acute nonlymphocytic leukemia.
|
Academic Article
|
Chromosome changes in hematologic malignancies.
|
Academic Article
|
Establishment of a leukemia cell line with i(12p) from a patient with a mediastinal germ cell tumor and acute lymphoblastic leukemia.
|
Academic Article
|
Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study.
|
Academic Article
|
Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia.
|
Academic Article
|
Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop.
|
Academic Article
|
Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.
|
Academic Article
|
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).
|
Academic Article
|
RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7.
|
Academic Article
|
Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461.
|
Academic Article
|
Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy.
|
Academic Article
|
t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia.
|
Academic Article
|
Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma.
|
Academic Article
|
The spectrum of somatic mutations in high-risk acute myeloid leukaemia with -7/del(7q).
|
Academic Article
|
Overexpression and knockout of miR-126 both promote leukemogenesis.
|
Academic Article
|
Therapy-related myeloid neoplasms in 109 patients after radiation monotherapy.
|